for the treatments of acute bipolar I disorder and schizophrenia. The NDA is supported by several clinical studies assessing the efficacy and safety of Bysanti™. Vanda Logo (PRNewsfoto/Vanda Pha ...

for the treatments of acute bipolar I disorder and schizophrenia. The NDA is supported by several clinical studies assessing the efficacy and safety of Bysanti™. Bysanti™ is a new chemical ...

In April, the American Psychiatric Association (APA) released a comprehensive treatment guideline for treating adults who have been diagnosed with schizophrenia. Titled "The Practice Guideline for ...

(Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) requesting marketing approval of Bysanti™ (milsaperidone) for the ...

Researchers at University of California campuses at Davis and San Diego have developed a new, neuroplasticity-promoting drug ...

Acute pancreatitis is a serious condition that causes the pancreas to become inflamed. It develops suddenly and can cause severe pain in the upper abdomen, often spreading to your back or left ...

Signs of acute respiratory failure include dizziness, shortness of breath, confusion, drowsiness, and a bluish discoloration of your lips, skin, or extremities. It can be life threatening and ...

Hallucinations and delusions are the most common symptoms. Psychosis can occur as part of many conditions, including schizophrenia and bipolar disorder. People with psychosis may experience ...

Mar. 21, 2025 — A new study has analyzed and compared the fatty acids in the blood of individuals with schizophrenia, of those with cannabis use disorder and of those with both diagnoses ...

Rising temperatures may not only affect physical health, but could also increase the burden of mental and behavioural disorders (MBD) like schizophrenia and depression by almost 50 per cent by 2050, ...